Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Covalon Technologies Ltd V.COV

Alternate Symbol(s):  CVALF

Healthcare Biotechnology
Covalon Technologies Ltd. is a patient-driven medical device company. Through a portfolio of patented technologies and solutions for advanced wound care, infection prevention, and medical device coatings, the Company offers gentler and more compassionate options for patients to heal with less infections, less pain, and better outcomes. Its solutions are designed for patients and made for care providers. It leverages its patented medical technology platforms and expertise in two ways: by developing products that are sold under Covalon’s name and by developing and commercializing medical products for other medical companies under development and license contracts. It provides a range of specialized medical devices, medical dressings and advanced medical technology designed for infection prevention, complex wound closure and perioperative care. Its perioperative care solutions provide antimicrobial protection of pre-operative skin, through postoperative incision care to scar prophylaxis.


TSXV:COV - Post by User

Covalon Technologies Ltd
Bullboard Posts
User Avatar Image
(11)
•••
Comment by zenvestingon May 22, 2015 1:52pm
97 Views
Post# 23755140

RE:Covalan continuing trade show march

RE:Covalan continuing trade show marchCovalon has introduced CovaWound, a new product line that's complimentry to their succesful ColActive Collagen dressings, but hasn't said a word about it to investors, as of yet:
CovaWound on Covalon's website

Their new products are also profiled on WoundSource.com already as well:
CovaWound on WoundSource.com

They've also attended two other industry conferences in the past month that they haven't PR'd (SAWC 4/29 - 5/3 & EWMA 5/13 - 5/15) and are going to WOCN again this year:
Covalon will be at

Covalon is focussed on building the business and isn't hyping their story to investors, this is the kind of company I like to invest in, it might take patience but a little DD shows this company is working hard and building a growing business.

Bullboard Posts
Dealroom for high-potential pre-IPO opportunities